Skip to content
Clinical Trials – home

Find therapies in clinical trials near you

recruiting
3 968
countries
28
conditions
2 103

10 trials match your criteria

Schizophrenia

Recruiting

Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Aripiprazole

Schizophrenia

Recruiting

Study on the Effectiveness of Aripiprazole and Paliperidone in Patients Experiencing Their First Episode of Schizophrenia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Aripiprazole

Schizophrenia

Recruiting

Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Aripiprazole

Anxiety disorder+2

Recruiting

Study on Personalized Dosing of Sertraline, Aripiprazole, and Risperidone for Patients with Mood, Anxiety, or Psychotic Disorders

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aripiprazole

Studying the Safety of Aripiprazole and Risperidone in Children and Adolescents with Autism Spectrum Disorder

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Aripiprazole

Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Amisulpride

Psychotic disorder+1

Not yet recruiting

Study on Reducing Antipsychotic Dose vs. Maintenance Treatment for Patients with Schizophrenia Using Haloperidol Decanoate, Risperidone, and Amisulpride

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Amisulpride

Schizophrenia

Not recruiting

Relative Bioavailability of LY03010 versus Paliperidone Palmitate (with Risperidone background) in Healthy Volunteers for Schizophrenia

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Risperidone

Psychotic disorder+1

Not recruiting

Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Amisulpride

Psychotic disorder

Not recruiting

Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Cannabidiol
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.